Skip to main content

Table 4 Imaging of abdominal-enhanced CT in the LMV group and the non-LMV group (%)

From: Clinical characteristics and prognosis of childhood-onset lupus mesenteric vasculitis as the initial presentation—a case–control study

Imaging

LMV group (n1 = 11)

Non-LMV group (n0 = 17)

P*

Intestinal wall thickening

11 (100.0)

0 (0.0)

0.000**

Peritoneal effusion

9 (81.8)

2 (11.8)

0.000**

Mesenteric vascular enhancement

6 (54.6)

0 (0.0)

0.001**

Hydronephrosis with ureteral dilatation

5 (45.5)

0 (0.0)

0.005**

Intestinal congestion and liquid–gas level

3 (27.3)

0 (0.0)

0.005**

Gastric mucosa thickening

3 (27.3)

0 (0.0)

0.005**

Thickening of the bladder wall

1 (9.1)

0 (0.0)

0.393

Splenomegaly

1 (9.1)

8 (47.1)

0.049**

Fatty liver

1 (9.1)

1 (5.9)

1.000

Hepatomegaly

0 (0.0)

6 (35.3)

0.055

Splenic infarction

0 (0.0)

1 (5.9)

1.000

Pancreatitis

0 (0.0)

1 (5.9)

1.000

  1. *Fisher’s exact inspection
  2. **The difference between the two groups was statistically significant (P < 0.05)